Comparison of very long-term clinical and angiographic outcomes of bare metal stent implants between patients with and without type 2 diabetes.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Primary Care Diabetes

• Publication date

  2017-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.pcd.2017.04.006PMID 28576662
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Six‐year prognosis of diabetic patients with coronary artery disease

  2012cited by this paper
• Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22 844 patient years of follow-up from randomised trials

  2012cited by this paper
• Comparison of three-year clinical outcomes after sirolimus-eluting stent implantation among insulin-treated diabetic, non-insulin-treated diabetic, and non-diabetic patients from j-Cypher registry.

  2011cited by this paper
• Long-term outcomes following coronary drug-eluting- and bare-metal-stent implantation.

  2010cited by this paper
• 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.

  2009cited by this paper
• Meta-analysis comparison (nine trials) of outcomes with drug-eluting stents versus bare metal stents in patients with diabetes mellitus.

  2008cited by this paper
• Endothelial dysfunction in diabetes mellitus

  2007cited by this paper
• [Clinical and angiographic predictors of restenosis after bare metal stent deployment in coronary artery disease patients complicated with diabetes].

  2006cited by this paper
• Percutaneous coronary interventions with drug eluting stents for diabetic patients

  2005cited by this paper
• Pathological analyses of long-term intracoronary Palmaz-Schatz stenting; Is its efficacy permanent?

  2004cited by this paper
• Short- and long-term results after multivessel stenting in diabetic patients.

  2004cited by this paper
• Clinical and Angiographic Predictors of Restenosis After Stent Deployment in Diabetic Patients

  2004cited by this paper
• Outcomes in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention in the Current Era: A Report From the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) Trial

  2004cited by this paper
• One-year follow-up after primary coronary intervention for acute myocardial infarction in diabetic patients. A substudy of the STENT PAMI trial.

  2001cited by this paper
• Long term outcome after coronary stent implantation: a 10 year single centre experience of 1000 patients

  1999cited by this paper
• Late coronary artery stenting in patients with acute myocardial infarction.

  1998cited by this paper
• Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement.

  1998cited by this paper
• Potential mechanisms promoting restenosis in diabetic patients.

  1996cited by this paper
• Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry.

  1996cited by this paper
• Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty.

  1995cited by this paper
• Effect of insulin on growth of cultured human arterial smooth muscle cells

  1981cited by this paper
• Effect of Insulin on the Proliferation of Cultured Primate Arterial Smooth Muscle Cells

  1975cited by this paper

• Effects of Sodium-Glucose Co-Transporter 2 Inhibitors on Vascular Cell Function and Arterial Remodeling

  2021cites this paper
• Canagliflozin inhibits vascular smooth muscle cell proliferation and migration: Role of heme oxygenase-1

  2020cites this paper
• Vildagliptin Reduces Stenosis of Injured Carotid Artery in Diabetic Mouse Through Inhibiting Vascular Smooth Muscle Cell Proliferation via ER Stress/NF-κB Pathway

  2019cites this paper